Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

ClinicalTrials.gov ID: NCT06865079

Public ClinicalTrials.gov record NCT06865079. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 7:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

53-Week Study Evaluating the Safety and Efficacy of Intra-articular (IA) Injections of TPX-100 vs Placebo in Subjects with Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Study identification

NCT ID
NCT06865079
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
OrthoTrophix, Inc
Industry
Enrollment
270 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 8, 2025
Primary completion
Mar 24, 2027
Completion
Apr 14, 2027
Last update posted
Feb 16, 2026

2025 – 2027

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Elite Clinical Network Scottsdale Arizona 85260 —
Noble Clinical Research Tucson Arizona 85704 —
Legent Orthopedic Hospital Carrolton California 75006 —
Medvin Clinical Research Covina California 91722 —
CORE Orthopaedic Medical Center Encinitas California 92024 —
Marvel Clinical Research (Elite Clinical Network) Huntington Beach California 92647 —
Medvin Clinical Research Center Riverside California 92518 —
Medvin Clinical Research Center Tujunga California 91042 —
Medvin Clinical Research Center Whittier California 90602 —
K2 Medical Research Maitland Florida 32751 —
Wellness Research Center Miami Florida 33135 —
Well Pharma Medical Research Miami Florida 33173 —
Las Mercedes Medical Research Miami Florida 33196 —
Drug Studies of America Marietta Georgia 30060 —
AMR Kansas City Kansas City Kansas 64114 —
University of Kansas Medical Center Kansas City Kansas 66160 —
AMR Lexington Lexington Kentucky 40509 —
Accurate Clinical Research Inc. Lake Charles Louisiana 70605 —
Mayo Clinic (Rochester) Rochester Minnesota 55905 —
Las Vegas Clinical Trials North Las Vegas Nevada 89030 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
Center for Clinical Research Winston-Salem North Carolina 27103 —
Hightower Clinical Oklahoma City Oklahoma 73102 —
University Orthopedics Center Altoona Pennsylvania 16602 —
University Orthopedics Center State College Pennsylvania 16801 —
AMR Knoxville Knoxville Tennessee 37909 —
Accurate Clinical Research, LLC Baytown Texas 77521 —
Texas Orthopedic Specialist Bedford Texas 76021 —
First Surgical Hospital Bellaire Texas 77401 —
Accurate Clinical Research Houston Texas 77089 —
Endeavor Clinical Trials San Antonio Texas 78229 —
CenExel Salt Lake City Utah 84107 —
Wasatch Clinical Research Salt Lake City Utah 84107 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06865079, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06865079 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →